205.24 - 207.41
139.95 - 221.69
4.54M / 6.59M (Avg.)
37.59 | 5.48
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
-21.08%
Negative net income growth while MCHP stands at 158.44%. Joel Greenblatt would see a comparative disadvantage in bottom-line performance.
2.47%
D&A growth well above MCHP's 1.42%. Michael Burry would suspect heavier depreciation burdens that might erode net income unless top-line follows suit.
55.77%
Some yoy growth while MCHP is negative at -114.28%. John Neff would see competitor possibly managing deferrals more aggressively for short-term advantage.
-8.70%
Both cut yoy SBC, with MCHP at -3.43%. Martin Whitman would view it as an industry shift to reduce stock-based pay or a sign of reduced expansions.
104.98%
Slight usage while MCHP is negative at -98.22%. John Neff would note competitor possibly capturing more free cash unless expansions are needed here.
1211.76%
AR growth while MCHP is negative at -36.52%. John Neff would note competitor possibly improving working capital while we allow AR to rise.
-288.46%
Negative yoy inventory while MCHP is 136.57%. Joel Greenblatt would see a near-term cash advantage if top-line doesn't suffer.
-125.49%
Both negative yoy AP, with MCHP at -448.54%. Martin Whitman would find an overall trend toward paying down supplier credit in the niche.
13.87%
Some yoy usage while MCHP is negative at -80.76%. John Neff would see competitor possibly generating more free cash from minor accounts than we do.
1150.00%
Well above MCHP's 44.04%. Michael Burry would worry about large intangible write-downs or revaluation gains overshadowing real performance.
1.85%
Some CFO growth while MCHP is negative at -1.49%. John Neff would note a short-term liquidity lead over the competitor.
12.70%
CapEx growth well above MCHP's 12.05%. Michael Burry would suspect heavier cash outlays that risk short-term free cash flow vs. competitor.
-12.70%
Negative yoy acquisition while MCHP stands at 0.00%. Joel Greenblatt sees potential short-term cash advantage unless competitor’s deals yield big synergy.
89.25%
Purchases well above MCHP's 44.05%. Michael Burry would see major cash outflow into securities vs. competitor’s approach, risking near-term FCF.
26.12%
Below 50% of MCHP's 69.82%. Michael Burry would see minimal near-term inflows vs. competitor’s liquidation approach.
15.36%
Growth well above MCHP's 11.48%. Michael Burry would suspect heavier intangible or side spending overshadowing competitor’s approach, risking short-term FCF.
185.12%
Investing outflow well above MCHP's 86.43%. Michael Burry sees possible short-term FCF risk unless these invests pay off quickly vs. competitor’s approach.
No Data
No Data available this quarter, please select a different quarter.
-30.91%
Negative yoy issuance while MCHP is 120.34%. Joel Greenblatt sees a near-term advantage in avoiding dilution unless competitor invests more effectively with the new shares.
-67.42%
We cut yoy buybacks while MCHP is 0.00%. Joel Greenblatt would question if competitor is gaining a per-share edge unless expansions justify holding cash here.